Stock screener

MEDP

Conviction 53HealthcareScan · Mon, Jul 20, 2026
MEDP$527.98-1.81%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
David J. Taylor
Vol MA14 319.03K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Medpace Holdings, Inc.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.medpace.com
Price527.98
Change-1.81%
Gap-0.46%
Rel volume1.82×
Avg volume342.95K
Avg $ vol180.68M
SMA 20528.54
SMA 50476.73
SMA 200515.97
Price vs 50+10.75%
Price vs 200+2.33%
MA stackmixed
50/200 cross
Supertrendup · 498.50
RSI (14)56
MACD hist-3.52
MACD crossbear · 5d
Stoch %K / %D15 / 31
ADX (14)32
+DI / −DI21 / 12
RSI divergence
MACD divergence
ATR %+3.24%
ADR %3.41%
52w high620.59
52w low308.88
From 52w high-14.92%
Above 52w low+70.93%
New 52w highNo
SqueezeOff
Bollinger width18.40%
%B0.49
Donchian pos67.51%
Donchian high567.91
Donchian low445.01
AVWAP (52w high)474.56
vs AVWAP high+11.26%
AVWAP (52w low)491.46
vs AVWAP low+7.43%
OBV trendUp
Chaikin MF (20)0.16
Today vs 20d1.82×
Avg vol (14d)319.03K
Avg vol (20d)342.95K
Avg $ vol (20d)180.68M
Market cap15.08B
RS 3m (vs SPY)-1.65%
RS 6m (vs SPY)-20.44%
RS line new highNo
Trend template5/8
Technical rank56.2
1 week-0.42%
1 month+15.51%
3 months+1.42%
6 months-14.57%
1 year+65.43%
YTD-7.54%
P/E33.42
P/B25.20
P/S5.96
P/FCF22.11
EPS15.28
Div yield
ROE75.40%
ROA21.18%
Debt/Eq0.00
Current0.85
EV/EBITDA
Gross margin
Net margin17.83%
Rev growth19.97%
EPS growth11.56%
Price target472.89
Target upside-10.43%
Analyst ratingHold
Institutional92.41%
Ent. value14.43B
Revenue706.6M
Net income123.87M
Gross profit
Free cash flow681.87M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out28.56M
Employees6.3K
ListedThu, Aug 11, 2016
Free float22.5M
Float %79.3%
Short interest2.13M
Days to cover5.9d
Short volume51.5%
Squeeze score64 / 100
Next earningsWed, Jul 22, 2026 · after (2d)
EPS forecast$4.08 · 3 est
Last EPS vs est$4.28 vs $3.74
Last surprise+14.4% beat
Setup gradeC
Conviction53 / 100
Pattern quality
Tech rank56.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance556.16
Support428.19
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MEDP · 7 recent

All disclosures →
MemberSideAmount
David J. Taylor
David J. Taylor
house · OH · traded 2026-05-15
Buy$1K–$15K
David J. Taylor
David J. Taylor
house · OH · traded 2026-01-29
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-04
Sell$1K–$15K
David J. Taylor
David J. Taylor
house · R · OH · traded 2025-07-23
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-24
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-07-22
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-01-13
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in MEDP · 5 buys · 2 sells

InsiderSideShares
EWALD STEPHEN P
General Counsel & Corp. Secy. · Common Stock · 2026-05-28
Sell16.35K
EWALD STEPHEN P
General Counsel & Corp. Secy. · Common Stock · 2026-05-28
Exercise16.35K
EWALD STEPHEN P
General Counsel & Corp. Secy. · Employee Stock Option (Right to Buy) · 2026-05-28
Exercise16.35K
Kraft Robert O.
Director · Stock Option (Right to Buy) · 2026-05-15
Grant1.11K
McCarthy Cornelius P. III
Director · Common Stock · 2026-05-15
Other
Gwadry-Sridhar Femida H.
Director · Stock Option (Right to Buy) · 2026-05-15
Grant1.11K
DAVENPORT FRED B JR
Director · Common Stock · 2026-05-15
Other
Carley Brian T
Director · Stock Option (Right to Buy) · 2026-05-15
Grant1.11K
Carley Brian T
Director · Common Stock · 2026-05-15
Other
McCarthy Cornelius P. III
Director · Stock Option (Right to Buy) · 2026-05-15
Grant1.11K

SEC filings

EDGAR filings in MEDP · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.